APA (7th ed.) Citation

H, J., D, S., B, P., JH, L., Y, R., J, L., . . . MK, S. (2026). Repositioning of Ertiprotafib via supramolecular assembly enables biomarker-guided therapy for acute kidney injury. Journal of nanobiotechnology, 24(1), . https://doi.org/10.1186/s12951-026-04357-7

Chicago Style (17th ed.) Citation

H, Jang, et al. "Repositioning of Ertiprotafib via Supramolecular Assembly Enables Biomarker-guided Therapy for Acute Kidney Injury." Journal of Nanobiotechnology 24, no. 1 (2026). https://doi.org/10.1186/s12951-026-04357-7.

MLA (9th ed.) Citation

H, Jang, et al. "Repositioning of Ertiprotafib via Supramolecular Assembly Enables Biomarker-guided Therapy for Acute Kidney Injury." Journal of Nanobiotechnology, vol. 24, no. 1, 2026, https://doi.org/10.1186/s12951-026-04357-7.